Zebra Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,672
| Closed | -$261K | – | 77 |
|
|
2022
Q3 | $261K | Sell |
13,672
-1,680
| -11% | -$32.1K | 0.99% | 43 |
|
|
2022
Q2 | $279K | Buy |
15,352
+1,361
| +10% | +$24.7K | 0.82% | 48 |
|
|
2022
Q1 | $353K | Sell |
13,991
-218
| -2% | -$5.5K | 0.81% | 39 |
|
|
2021
Q4 | $392K | Sell |
14,209
-5,239
| -27% | -$145K | 0.63% | 55 |
|
|
2021
Q3 | $628K | Sell |
19,448
-10,389
| -35% | -$335K | 0.76% | 38 |
|
|
2021
Q2 | $912K | Sell |
29,837
-3,223
| -10% | -$98.5K | 1.07% | 28 |
|
|
2021
Q1 | $1.01M | Buy |
+33,060
| New | +$1.01M | 1.11% | 24 |
|
|
2018
Q4 | – | Sell |
-4,361
| Closed | -$201K | – | 413 |
|
|
2018
Q3 | $201K | Buy |
+4,361
| New | +$201K | 0.09% | 383 |
|
|
2018
Q2 | – | Sell |
-12,248
| Closed | -$362K | – | 353 |
|
|
2018
Q1 | $362K | Buy |
12,248
+3,886
| +46% | +$115K | 0.13% | 270 |
|
|
2017
Q4 | $287K | Sell |
8,362
-1,673
| -17% | -$57.4K | 0.1% | 287 |
|
|
2017
Q3 | $363K | Buy |
10,035
+995
| +11% | +$36K | 0.12% | 229 |
|
|
2017
Q2 | $234K | Buy |
+9,040
| New | +$234K | 0.07% | 244 |
|